English  |  正體中文  |  简体中文  |  總筆數 :2856704  
造訪人次 :  53689032    線上人數 :  1586
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"huang c s"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 21-45 / 788 (共32頁)
1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2022-09-09T04:21:27Z Sofosbuvir/Velpatasvir for Hepatitis?C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan Cheng P.-N.; Mo L.-R.; Chen C.-T.; Chen C.-Y.; Huang C.-F.; Kuo H.-T.; Lo C.-C.; Tseng K.-C.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Chou K.-H.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Cheng C.-Y.; Tsai M.-C.; Liu C.-J.; Dai C.-Y.; Lin H.-C.; JIA-HORNG KAO; Chuang W.-L.; Yu M.-L.; TACR investigators
臺大學術典藏 2022-09-09T04:21:25Z Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals Chen Y.-C.; Chang T.-S.; Chen C.-H.; Cheng P.-N.; Lo C.-C.; Mo L.-R.; Chen C.-T.; Huang C.-F.; Kuo H.-T.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Hsiung C.-K.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Dai C.-Y.; JIA-HORNG KAO; Chuang W.-L.; Lin H.-C.; Chen C.-Y.; Tseng K.-C.; Yu M.-L.; on behalf of TACR investigators
臺大學術典藏 2022-09-09T04:21:21Z Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR) Huang C.-F.; Tseng K.-C.; Cheng P.-N.; Hung C.-H.; Lo C.-C.; Peng C.-Y.; Bair M.-J.; Yeh M.-L.; Chen C.-H.; Lee P.-L.; Lin C.-Y.; Kuo H.-T.; Chen C.-T.; Yang C.-C.; Huang J.-F.; Tai C.-M.; Hu J.-T.; Lin C.-L.; Su W.-W.; Tsai W.-L.; Huang Y.-H.; Cheng C.-Y.; Lin C.-L.; Wang C.-C.; Yang S.-S.; Mo L.-R.; Chen G.-Y.; Chang C.-C.; Wang S.-J.; Huang C.-S.; Hsieh T.-Y.; Lin C.-W.; Lee T.-H.; Chong L.-W.; Huang C.-W.; Chang S.-N.; Tsai M.-C.; Hsu S.-J.; JIA-HORNG KAO; Liu C.-J.; Liu C.-H.; Lin H.-C.; Lee M.-H.; Tsai P.-C.; Dai C.-Y.; Chuang W.-L.; Chen C.-Y.; Yu M.-L.
臺大學術典藏 2022-09-09T04:21:18Z Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4–6 infection: Real-world evidence from a nationwide registry in Taiwan Lo C.-C.; Huang C.-F.; Cheng P.-N.; Tseng K.-C.; Chen C.-Y.; Kuo H.-T.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Chen C.-T.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Mo L.-R.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Hsiung C.-K.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Liu C.-J.; Dai C.-Y.; Chuang W.-L.; Lin H.-C.; JIA-HORNG KAO; Yu M.-L.; TACR investigators
臺大學術典藏 2022-08-23T02:35:03Z Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-responders Dai M.-S.; Liu L.-C.; Wang M.-Y.; Lo C.; Chang S.; Tan K.T.; Chen S.-J.; SUNG-HSIN KUO; Huang C.-S.; Yeh D.-C.; Tseng L.-M.; Lee Y.-H.; Chen S.-T.; Lin P.-H.
臺大學術典藏 2022-08-19T00:21:16Z Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-na?ve patients with locally advanced or metastatic breast carcinoma Cheng A.-L.; Chang K.-J.; Chen M.M.; Lu Y.-S.; Bu C.-F.; CHIUN HSU; Huang C.-S.; Chao T.-Y.
臺大學術典藏 2022-08-19T00:21:10Z A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer Lin C.-C.; Cheng A.-L.; Hsu C.-H.; Lu Y.-S.; CHIUN HSU; Yeh K.-H.; Wu C.-Y.; Huang C.-S.; Yang C.-H.
臺大學術典藏 2022-08-19T00:21:02Z Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin Cheng A.-L.; Lin C.-H.; Chang K.-J.; Kuo W.-H.; CHIUN HSU; Lee W.-C.; Liau J.-Y.; Huang C.-S.; Lu Y.-S.; Shao Y.-Y.; Kuo K.-T.; Hu F.-C.
臺大學術典藏 2022-08-19T00:20:59Z Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era Lu Y.S.; Cheng A.L.; Kuo W.H.; Chen I.C.; Lin C.H.; Huang C.S.; Lien H.C.; CHIUN HSU
臺大學術典藏 2022-08-19T00:20:54Z The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclines Cheng A.-L.; Lu Y.-S.; Chen W.-W.; Chang D.-Y.; Huang S.-M.; Lin C.-H.; CHIUN HSU; Lin M.-H.; Huang C.-S.
臺大學術典藏 2022-08-12T06:29:13Z HER-2/neu overexpression in Chinese breast cancers: correlation with other prognostic factors. Huang C.S.; Chen Y.C.; Wang M.; Lin J.K.; KING-JEN CHANG
臺大學術典藏 2022-08-12T06:29:13Z Breast cancer vascularity: Color Doppler sonography and histopathology study Lee W.-J.; Chu J.-S.; Huang C.-S.; Chang M.-F.; KING-JEN CHANG; Chen K.-M.
臺大學術典藏 2022-08-12T06:29:13Z Photodynamic effect on breast and colon cancer cells of use of merocyanine 540 as a photosensitizer Huang C.-S.; Huang S.-H.; Lin T.-I.; KING-JEN CHANG
臺大學術典藏 2022-08-12T06:29:10Z Ages at different reproductive events, numbers of menstrual cycles in between and breast cancer risk Chie W.-C.; Fu C.-M.; Lee W.-C.; Li C.-Y.; Huang C.-S.; KING-JEN CHANG; Lin R.-S.
臺大學術典藏 2022-08-12T06:29:06Z Body size as a factor in different ages and breast cancer risk in Taiwan Chie W.-C.; Li C.-Y.; Huang C.-S.; KING-JEN CHANG; Lin R.-S.
臺大學術典藏 2022-08-12T06:29:05Z Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives Chie W.-C.; Li C.-Y.; Huang C.-S.; KING-JEN CHANG; Yen M.-L.; Lin R.-S.
臺大學術典藏 2022-08-12T06:29:03Z Proliferating cell nuclear antigen (PCNA) immunolabeling as a prognostic factor in invasive ductal carcinoma of the breast in Taiwan Chu J.-S.; Huang C.-S.; KING-JEN CHANG
臺大學術典藏 2022-08-12T06:29:02Z The prognostic significance of tumor angiogenesis in Taiwanese patients with invasive ductal breast carcinomas Chu J.-S.; Huang C.-S.; KING-JEN CHANG
臺大學術典藏 2022-08-12T06:29:01Z Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset) Lo Y.-L.; Yu J.-C.; Huang C.-S.; Tseng S.-L.; Chang T.-M.; KING-JEN CHANG; Wu C.-W.; Shen C.-Y.
臺大學術典藏 2022-08-12T06:28:59Z Microcalcifications of non-palpable breast lesions detected by ultrasonography: Correlation with mammography and histopathology Huang C.-S.; Wu C.-Y.; Chu J.-S.; Lin J.-H.; Hsu S.-M.; KING-JEN CHANG
臺大學術典藏 2022-08-12T06:28:58Z Measurement of the quality of life during different clinical phases of breast cancer Chie W.-C.; Huang C.-S.; Chen J.-H.; KING-JEN CHANG
臺大學術典藏 2022-08-12T06:28:57Z p27 expression as a prognostic factor of breast cancer in Taiwan Chu J.-S.; Huang C.-S.; KING-JEN CHANG
臺大學術典藏 2022-08-12T06:28:56Z Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan Huang C.-S.; Shen C.-Y.; KING-JEN CHANG; Hsu S.-M.; Chern H.-D.
臺大學術典藏 2022-08-12T06:28:56Z Association between N-acetyltransferase 2 (NAT2) genetic polymorphism and development of breast cancer in post-menopausal Chinese women in Taiwan, an area of great increase in breast cancer incidence Huang C.-S.; Chern H.-D.; Shen C.-Y.; Hsu S.-M.; KING-JEN CHANG
臺大學術典藏 2022-08-12T06:28:55Z Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: A multigenic study on cancer susceptibility Huang C.-S.; Chern H.-D.; KING-JEN CHANG; Cheng C.-W.; Hsu S.-M.; Shen C.-Y.

顯示項目 21-45 / 788 (共32頁)
1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目